Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 17 Jun 2026 for Eloxx Pharmaceuticals, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Domicilium Real Estate Fund III LP: trading record in brief
Domicilium Real Estate Fund III LP discloses dealings in Eloxx Pharmaceuticals, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 27 May 2026 to 10 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 17 June 2026, reports a transaction in Eloxx Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Domicilium Real Estate Fund III LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
238,422 sharescommon stock, $0.01 par value per shareSEC:0000919574-26-004021:0
361,578 sharescommon stock, $0.01 par value per shareSEC:0000919574-26-004021:1
113,636 shares0Common Stock, $0.01 par value per shareSEC:0000919574-26-003845:0
3 of 3 declarations
